Cognitive enhancement therapy for schizophrenia

Lancet

Volumn 364, Issue 9452, 2004, Pages 2163-2165

  Ran, Mao Sheng ^a   Chen, Eric Yu Hai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE THERAPY; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; INTERVIEW; MENTAL DEFICIENCY; MENTAL PATIENT; NOTE; OUTPATIENT CARE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; PSYCHOSOCIAL CARE; SIMPLE SCHIZOPHRENIA;

EID: 10944272683     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17609-5     Document Type: Note

References (15)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 349:1997;1436-1442
2. Mohamed S, Paulsen JS, O'Leary D, Arndt S, Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry. 56:1999;749-754
3. Spaulding WD, Reed D, Sullivan M, Richardson C, Weiler M. Effects of cognitive treatment in psychiatric rehabilitation. Schizophr Bull. 25:1999;657-676
4. Bell M, Bryson G, Greig T, Corcoran C, Wexler BE. Neurocognitive enhancement therapy with work therapy: effect on neuropsychological test performance. Arch Gen Psychiatry. 58:2001;763-768
5. Hogarty GE, Flesher S, Ulrich R, et al. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry. 61:2004;866-876
6. Rund BR. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr Bull. 24:1998;425-435
7. Leucht S, Barnes TR, Kissling W, Engel RR, Correll C, Kane JM. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry. 160:2003;1209-1222
8. Hogarty GE, Greenwald D, Ulrich RF, et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family II: effects on adjustment of patients. Am J Psychiatry. 154:1997;1514-1524
9. Ran MS, Xiang MZ, Chan CLW, et al. Effectiveness of psychoeducational intervention for rural Chinese families experiencing schizophrenia: a randomised controlled trial. Soc Psychiatry Psychiatr Epidemiol. 38:2003;69-75
10. Xiang MZ, Ran M, Li S. A controlled evaluation of psychoeducational family intervention in a rural Chinese community. Br J Psychiatry. 165:1994;544-548
11. Hogarty GE, Flesher S. Practice principles of cognitive enhancement therapy for schizophrenia. Schizophr Bull. 25:1999;693-708
12. Schooler NR, Keith SJ, Severe JB, et al. Relapse and rehospitalization during maintenance treatment of schizophrenia: the effects of dose reduction and family treatment. Arch Gen Psychiatry. 54:1997;453-463
13. Rattok J, Ben-Yishay Y, Lakin P., et al. Outcome of differential mixes in a multidimensional neuropsychological rehabilitation program. Neuropsychology. 6:1991;395-415
14. Bilder RM, Turkel E, Lipschutz-Borch L, Lieberman JA. Antipsychotic medication effects on neuropsychological functions. Psychopharmacol Bull. 28:1992;353-366
15. Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder? Schizophr Bull. 25:1999;309-319